Month: February 2015

HCi Viocare Enters UK Innovation Competition with New Concept in Medical Imaging

ATHENS, Greece, via ETELIGIS INC., 02/25/2015 – – HCi Viocare (the "Company") (OTCQB: VICA), today announced that it has created a new product concept for real-time, non-contact and non-invasive medical imaging as part of its entry to a ‘Technology Inspired Innovation’ competition held by Innovate UK, the United Kingdom’s innovation agency.

Winners in the competition are awarded funding to support feasibility studies into new technologies with substantial and scalable commercial potential, and £2 million will be awarded in March.

HCi Viocare’s proposed solution stems from developments in the company’s ‘SocketFit’ technology and would open the company’s R&D portfolio to the wider medical imaging market.

For further information about HCi Viocare please visit the Company’s website at http://www.viocare.eu.

On behalf of the Board of Directors of HCi Viocare

Sotirios Leontaritis,

Chief Executive Officer and President

About HCi Viocare

HCi Viocare has a dual, complementary business model of 1) creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and 2) developing a portfolio of biomedical technologies to address unmet needs in the diabetic foot, P&O and other health & wellbeing areas, for licensing to established industry participants.

The company is listed on the OTC Markets in the USA, has its executive office in Athens, Greece and R&D centre in Glasgow, UK.

Forward Looking Statements

This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company’s Quarterly, Annual and Current Reports filed with the United States Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove correct, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company’s forward-looking statements. In particular, the Company has only recently acquired its first operational Prosthetics & Orthotics (P&O) clinic and is continuing development efforts for its other biomedical technologies. There is no assurance that the Company will be successful in its ongoing expansion and development efforts, nor that it will be successful in receiving an award or grant for any of its new technology concepts. Except as required by law, HCi Viocare disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that HCi Viocare files from time to time with the SEC, including its Annual, Quarterly and Current Reports.

CONTACT:

HCi Viocare

Sotirios Leontaritis

Chief Executive Officer and President

info

http://www.viocare.eu

SOURCE: HCi Viocare

Reeltime Partners Executive Producers Todd Crites and Jackson Nyguen Appear on Life Angelz Talk Radio’s Traci Lynn Program

SPRING HILL, FL, United States, via ETELIGIS INC., 02/25/2015 – – ReelTime Rentals, Inc. (OTC Pink: RLTR) (PINKSHEETS: RLTR), announced that ReelTime Partners Todd Crites and Jackson Nyguen appeared on latalkradio.com’s Traci Lynn radio program. During the one hour program, Crites and Nyguen entered into open and frank discussions on how they got started in the business, their accomplishments and the challenges of working alongside elite athletes/sports celebrities such as Floyd Mayweather, Mike Tyson, BJ Penn, Manny Pacquiao, and Oscar De La Hoya to name a few.

ReelTime Partners Executive producer and Emmy Award winner Jackson Nyguen was quoted as saying, “I just fell into this line of work. Kinda fell in love with what was happening behind the scenes. There are different approaches to storytelling whether you interview Magic Johnson or Mike Tyson.” Nyguen also spoke of how he met Todd Crites on the critically acclaimed Fox sports series, “Beyond the Glory” and was “drafted” to come work with Crites on prime sporting events such as The Olympics, covering the ‘A’ venue figure skating and gymnastics as well as the prestigious Triple Crown.

ReelTime Partner Director and Peabody award winning editor Todd Crites stated, “Even the people you think are the most mundane have the coolest of stories. Finding the story in anything is the ticket.” Crites didn’t set out to be an editor. He preferred directing but an opportunity arose to edit – and was actually good at.

A life changing opportunity dropped from the sky in January 2014 when Crites and Nguyen secured the rights to the true story demonic possession of Latoya Ammons and her family. The movie is now in development at Relativity Media and expected to go into pre-production later this year. Crites and Nyguen told Ms. Lynn the Oscar winning Director Lee Daniels is attached to direct the movie. Mr. Daniels is known for “Precious,” “The Butler,” and the Fox hit “Empire.” Crites continued, “We did not want to make an atypical horror movie.” Jackson added, “2014 is the year of our renewed spirituality.” Both men were cynical but quickly realized there was much more of her story to be told. More importantly it really did happen.

Tracy Lynn’s “Life Angelz” radio broadcast can be heard at http://www.latalkradio.com/Angelz.php.

About ReelTime:

ReelTime Partners www.reeltime.com is in the business of identifying and monetizing individuals and companies who have been thrust into the public eye through the media. This awareness may come as a result of being featured on a TV show, newsworthy event, or viral social media exposure. Most individuals and companies are not prepared to monetize such exposure and often times find the exposure passes without having used it to their advantage. ReelTime through its partners is uniquely positioned to capitalize on the exposure and to maximize the benefits. Maximizing the opportunity may be achieved via merchandising, leveraging exposure into relationships, creating and marketing new revenue streams for existing products, and launching new products. ReelTime also helps increase the exposure that its partners receive and aid in the shaping of its image.

Safe Harbor for Forward-Looking Statements:

When used in this statement, the words “may,” “will,” “except,”‘ anticipate,” “continue,” “estimate,” “project,” intend” and similar expressions are intended to identify forward-looking statements within the meaning of Section 27a of the securities act of 1933 and Section 21e of the Securities Exchange Act of 1934 regarding events, condition, and financial trends that may affect the Company’s future plans of operations, business strategy, operating results, and financial position. Persons reviewing this report are cautioned that and forward-looking statements are not guarantees of future performance and are subject to risk and uncertainties and those actual results may differ materially from those include within the forward-looking statements as a result of varying factors. Such factors include among other things, uncertainties, relating to our success in judging consumer preferences, financing our operations, entering into strategic partnerships, engaging management, seasonal and period to period fluctuations in sales, failure to increase market share or sales inability to service outstanding debt obligations dependents on a limited number of customers, increased production costs or delays in production of new products intense competition within the industry, inability to protect the intellectual property in the international market for our products, changes in market conditions and other matters disclosed by us in our public filings from time to time, Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

CONTACT:

James Hodge

www.reeltime.com

(352) 573-6130

SOURCE: ReelTime Rentals, Inc.

GeckoSystems Announces Significant Contract Negotiations with Intl. Japanese Co.

2

CONYERS, GA, United States, via ETELIGIS INC., 02/25/2015 – – GeckoSystems Intl. Corp. (OTC Pink: GOSY) (PINKSHEETS: GOSY) announced today that the company has entered into significant contract negotiations with an internationally known Japanese company. For over seventeen years GeckoSystems has dedicated itself to development of "AI Mobile Robot Solutions for Safety, Security and Service™."

"While this whirlwind tour last December was an extremely tiring trip with a full agenda, it was a very productive one, now resulting in determining appropriate terms and conditions with a high volume Japanese manufacturer, taking us one step closer to important collaborations with several other established Japanese companies,” commented Martin Spencer, CEO, GeckoSystems Intl. Corp.

For several years, GeckoSystems has had Japanese representation in the Pacific Rim due to the capable assistance of Mr. Hajime Yasumatsu and his associate, Mr. Katsuji Fujii. Due to their hard work in the last 3-4 years, numerous discussions have been initiated and are ongoing. "Lou," one of the company’s BaseBot™ prototypes, has successfully demonstrated its "loose crowd" level of mobile robot autonomy to several Japanese firms.

"Due to a confluence of several ‘sea change’ events in hardware cost reduction and the rapid expansion of the emerging trillion dollar service robotics industry in Asia, it was time for me to meet personally with the Japanese companies that we have had ongoing discussions with for several years. Our BaseBot prototype has been available to these companies for over a year now, but with NDAs in place I was able to shed new light on the magic of SafePath™ navigation and our AI architecture. I was greeted with genuine hospitality and interest and I look forward to solidifying our relationship with some, if not all of these partners in the new year," said Spencer.

The confluence of factors referred to by Spencer include:

– a 36% increase in the dollar’s purchasing power in Japan since January of 2013. The cost of manufacturing in Japan has now fallen dramatically. The Yen is expected to continue to weaken against the dollar and this will benefit many US businesses, including GeckoSystems.

– In the last year Intel introduced a new low power x86 single board computer (SBC), the "Edison" that retails for $50 each. It was designed expressly for the mobile market, the "Internet of Things," (IoT). Previously, the equivalent x86 SBC system was over $200 per system. That new reality enables a direct cost of manufacturing reduction for all the computer systems on GeckoSystems’ CareBot(tm) of over 60%. The company expects their fifth generation CareBot, now in development, to have an MSRP of less than $5,000.

– Increased interest by Japanese car manufacturers in AI navigation for the automobile.

– Continued pressure on Japanese businesses to improve and reduce the cost of caring for the Japanese elderly population with the assistance of personal service robots.

“As our 1300+ shareholders are well aware, due to our recent marketing progress and movement on the OTC to Limited Information, our stock price has appreciated not insignificantly. As would be prudent, due to the delicacy and sensitivity of these contractual negotiations, we cannot reveal more than what we have in this press release. We are continuing our commitment to marketing and licensing our AI software solutions in the U.S. and abroad in order to limit dilution of our stock and maximize shareholder value,” concluded Spencer.

About GeckoSystems:

GeckoSystems has been developing innovative artificial intelligence robotic technologies for over seventeen years. It is CEO Martin Spencer’s dream to make people’s lives better through robotic systems technology.

An overview of GeckoSystems’ progress containing over 700 pictures and 120 videos can be found at http://geckosystems.com/timeline/.

Safe Harbor:

Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company’s future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. The Company is a development stage firm that continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company’s actual results may differ materially from expected results.

CONTACT:

GeckoSystems Intl. Corp.

Telephone:

Domestic/International: +1 678-413-9236

Fax: +1 678-413-9247

Website: http://geckosystems.com/

SOURCE: GeckoSystems Intl. Corp.

Peartrack Security Systems, Inc. Announces Appointment of Phil Woolas to Board of Directors

SANTA MONICA, CA, United States, via ETELIGIS INC., 02/24/2015 – – PearTrack Security Systems, Inc. (“PearTrack” or the “Company”) (OTCQB: PTSS) announced today that Mr. Phil Woolas has been appointed to the Company’s board of directors.

Mr. Woolas, age 55, comes with a wealth of experience in business in a multitude of different capacities in both the United States and the United Kingdom. He is a principal and co-founder of Wellington Street Partners, Ltd., a political and business consultancy firm headquartered in the United Kingdom. Prior to his position with Wellington, Mr. Woolas was the Labor Party Member of Parliament for 13 years, holding the seat of Oldham East & Saddleworth. He also served as Parliamentary Private Secretary to the Minister of State for Transport, Lord Commissioner of the Treasury, deputy leader of the House of Commons, Minister of State for Local Government and Regeneration, Minister of State for Civil Contingency, Minister of State for Environment, and Minister of State for Immigration and Customs. Mr. Woolas also served as Minister for the North West of England, and was a leading member of the Tony Blair and Gordon Brown Governments.

Prior to his time in Parliament, in 1984 Mr. Woolas was President of the United Kingdom National Union of Students and went on to a successful career in television where he worked initially as a researcher and investigative journalist for ITV and subsequently as a producer for BBC Newsnight and Channel Four News. He then entered politics as Head of Communications and Campaigns for the GMB trade union. He has also published numerous articles and essays and is a Fellow of the Royal Society of Arts.

On his appointment, Mr. Woolas comments, “I am thrilled to be involved in this cutting edge company which uses the best of Anglo-American technology and innovation to improve worldwide security. I very much look forward to contributing to the growth of PearTrack."

The Pear Track team believes that a diverse set of ideas and knowledge is essential to achieve its goal of being a high performing force to mitigate security risks associated with the movement of people and goods, and welcomes Mr. Woolas to the PearTrack organization.

About PearTrack Security Systems, Inc.:

Headquartered in Santa Monica, CA, PearTrack Security Systems, Inc. (OTCQB: PTSS), is a holding company with wholly-owned subsidiaries, including PearTrack Systems Group Limited (“PTSG”). This innovative company has developed, manufactured and commercialized a GPS tracking system, as well as devices that target non-powered assets with proprietary long life battery systems. The Company is currently enhancing its GPS tracking products, specifically assessing the areas of growth in M2M Telematics and Remote/Mobile Asset Tracking and Management, with particular emphasis on the intermodal container market. For more information: www.PearTrack.com.

CONTACT:

Media Contact:

Rachel Jiang

PearTrack Security Systems, Inc.

info

310-899-3900

Investor Contact:

Rachel Jiang

PearTrack Security Systems, Inc.

info

310-899-3900

SOURCE: PearTrack Security Systems, Inc.

Force Minerals Corporation Finalizes Acquisition of Crypto Currency Digital Mining Company; New Commerce Platform for BTC Transactions Under Development

Dynamo Billing System Launch.docx

IRVINE, CA, United States, via ETELIGIS INC., 02/24/2015 – – Force Minerals Corporation (OTC Pink: FORC) (PINKSHEETS: FORC), is pleased to announce the Company has completed acquisition of an established Crypto Currency digital mining company and its digital mining assets. The acquisition is now finalized.

The acquisition of Digital Mining Corporation, a developing Crypto Currency and Alt Currency Mining Corporation is finalized and the company is now moving forward in executing its business plan, which will concentrate in two primary divisions of operations. These divisions will include mining, mining pools, trading and arbitrage across all crypto currencies. The second division of operations will include the development of crypto security features particular to Bitcoin for merchants.

The company is developing a platform which will allow merchants to utilize, by subscription, the ability to confirm the authenticity of Bitcoin being offered as payment on a much timelier basis than currently available. Bitcoin transactions can take between half a minute to several minutes to confirm the authenticity of the Bitcoin being offered as payment with larger transactions involving several Bitcoin taking up to 15 minutes or more. The company believes that upon successful development of its platform the transaction times can be reduced to a few seconds, no matter how large.

“We believe this new transaction platform will be a significant game changing technology for merchants utilizing Bitcoin,” states, company President, Mr. Nate Lewis. “Companies such as Microsoft, Dell and many others with collective annual revenues of over 180 Billion now accept Bitcoin and the market is growing worldwide. We look forward to becoming a key developmental company in the Bitcoin and Crypto Currency markets in the future.”

Upon the successful implementation of this process the company will expand to other relative Crypto Currencies as opportunities become available.

Forward-Looking Statements:

This news release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey Company progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the Company at this time, actual results may differ materially and are subject to risk and uncertainties. Factors that may cause actual results to differ include without limitation: dependence on key personnel and suppliers; FORC’s ability to commercialize its technology; ability to defend intellectual property; material and component costs; competition; economic conditions; consumer demand and product acceptance, and availability of growth capital.

Additional considerations and risk factors are set forth in reports filed on Form 8-K and 10-K with the SEC and other filings. Readers are cautioned not to place undue reliance upon these forward-looking statements; historical information is not an indicator of future performance. The Company undertakes no obligation to update publicly any forward-looking statements.

CONTACT:

Force Minerals Corporation

President:

Mr. Nathaniel Lewis

1-970-660-8197

www.digitalminingcorp.com

ir

SOURCE: Force Minerals Corporation

PMX Communities Inc. Launches www.VacationerBox.com Online Head Shop

VANCOUVER, BC, Canada, via ETELIGIS INC., 02/24/2015 – – PMX Communities Inc. (OTCQB: PMXO), launches www.VacationerBox.com a unique kits only paraphernalia shop.

PMX Communities, Inc. hopes our new online head shop will be the first of many initiatives for the company in 2015. Our paraphernalia kits include items such as smoking pipes, rolling papers, vaping pens, soy scented candles, and lip and hand balms. Online pre-ordering and a call-in order ahead system is available for consumers planning trips.

“The Vacationer Box concept is finally live and we have begun our cannabis footprint rollout. 2015 looks to be our most exciting year as we put our boots down in this newly commercialized cannabis industry both stateside and in Canada,” stated Meris Kott of PMX Communities, Inc.

PMX Communities, Inc. was only a precious metals incubator company, having launched the MGIV gold terminal that allows consumers to purchase varying denominations of fine gold bullion bars and coins with a touch of a screen and a swipe of a card. In 2014, PMX expanded their terminal product line with the introduction of the LXIV BUD BOX terminal focused on becoming a dispensing delivery system for MJ and MMJ dispensaries.

Forward-Looking Statements

Certain statements made by the Company and its management on its behalf in this release and other periodic, oral and written statements, regarding the Company operating performance, events or developments that the Company believes or expects to occur in the future, including those that discuss anticipated financial results, strategies, goals, outlook or other non-historical matters, or which relate to future sales, earnings, expectations, growth of the Company or of the market for its products and services, or general belief in the Company’s expectations of future operating results are "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements are subject to risks and uncertainties, including but not limited to product demand, market and customer acceptance, competition, pricing, working capital considerations, and as otherwise discussed in the Company’s SEC filings. Such forward-looking statements are subject to change at any time, and the Company’s actual results may differ materially from anticipated results. The Company undertakes no obligation to update or revise any of such statements to reflect subsequent events or circumstances.

CONTACT:

PMX Communities Inc.

(561) 210-5349

info

@pmxgold

http://www.pmxgold.com

SOURCE: PMX Communities Inc.

China Commercial Credit Receives Nasdaq Delisting Notice

Ex 99.1 CCCR Delisting Press Release.docx (00345258-2).DOCX

WUJIANG, China, via ETELIGIS INC., 02/24/2015 – – China Commercial Credit, Inc. (NasdaqCM: CCCR) (NASDAQ: CCCR), a microfinance company providing financial services to small-to-medium enterprises (SMEs), farmers and individuals in Jiangsu Province, today said it has received a notice from The Nasdaq Stock Market notifying the Company that, since the Company failed to file the Form 10-Q for the quarter ended September 30, 2014 (the “Q3 10-Q”) with the Securities and Exchange Commission by the required date of February 17, 2015, pursuant to Nasdaq Listing Rule 5810 (b), trading of the Company’s common stock will be suspended from The Nasdaq Capital Market at the opening of business on March 2, 2015. In connection with such suspension a Form 25-NSE will be filed by Nasdaq with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market, unless the Company requests an appeal of this determination.

The Company has appealed the above determination to a Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Nasdaq has granted a 15-day stay of the suspension until March 13, 2015 and notified the Company that the hearing is scheduled for April 16, 2015. The Company has requested a further stay of the suspension through the hearing date.

About China Commercial Credit

China Commercial Credit (http://www.chinacommercialcredit.com), founded in 2008, provides business loans and loan guarantee services to small-to-medium enterprises (SMEs), farmers and individuals in China’s Jiangsu Province. Due to recent legislation and banking reform in China, these SMEs, farmers and individuals — which historically had been excluded from borrowing funds from State-owned and commercial banks — are now able to borrow money at competitive rates from microfinance lenders.

Investors seeking additional information on CCCR or wishing to register for company Email Alerts may go to http://www.ir-site.com/china-commercial-credit/default.asp or the Asia IR/PR client page at http://asia-irpr.com/clients/cccr/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of United States securities laws. You should not rely upon forward-looking statements as predictions of future events. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or to changes in our expectations. You should review the factors described in the section entitled "Risk Factors" in our Form 10-Q filed with the SEC on February 17, 2015 and other documents we file from time to time with the SEC. We qualify all of our forward-looking statements by these cautionary statements.

CONTACT:

Jimmy Caplan

Asia IR/PR

512-329-9505

jimmy

SOURCE: China Commercial Credit, Inc.

Entia Biosciences Updates Investors with an Annual Shareholder Letter

Entia Biosciences Updates Investors With An Annual Shareholder Letter

SHERWOOD, OR, United States, via ETELIGIS INC., 02/24/2015 – – Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of Nutrigenomics, released today the following Annual Shareholder Letter by Marvin S. Hausman MD, Chairman and CEO.

Dear Shareholders, Friends and GROH® Product Clients:

In a few words, during 2014, Entia Biosciences experienced wonderful successes on many fronts and in many forms. We saw exciting progress on the scientific front regarding the two compounds most important to our Company’s success…Ergothioneine and Vitamin D2. Likewise, there was significant forward progress regarding our own medical discovery efforts, research advancement as well as our company’s participation in both medical foods and beauty salon industry involvement and professional sponsorship. Lastly, but most rewarding of all, our GROH® Health and Beauty products attained significant new highs in sales and market penetration. All indications point to even greater success in 2015.

So that I may make sure all reading this letter thoroughly grasp the unqualified progress we made this last year, here’s the punch line: Sales of our GROH® line of cosmeceuticals produced more top-line revenues in one month than Entia has ever generated in a single quarter and practically any set of whole years! We are very excited about the progress in this business segment and encourage our investors to stay tuned for additional data and trends that should reward you as shareholders.

Let’s first discuss the scientific research support released this past year that is so important to the foundation of our Company’s future success. Remember, we are the only commercial proponents regarding the health benefits of Ergothioneine and Vitamin D-2 when ingested or even applied topically as a wellness and beauty aid. The scientific papers in peer-reviewed journals supporting our effort include:

– Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells. Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte, and George P. H. Leung . J Pharmacol Exp Ther 350:691–700, September 2014. This study showed that the presence of the Ergothioneine Transporter allowed Ergothioneine to be taken up by blood vessel wall cells with resultant control of endothelial dysfunction. The major significance and potential application to human health is the fact that endothelial dysfunction involving blood vessel wall cells plays a major role in hardening of the arteries and coronary heart disease.

– Organic Cation Transporter-Mediated Ergothioneine Uptake in Mouse Neural Progenitor Cells Suppresses Proliferation and Promotes Differentiation into Neurons. Takahiro Ishimoto, Noritaka Nakamichi, Hiroshi Hosotani, Yusuke Masuo, Tomoko Sugiura, Yukio Kato. PloS One 9(2): e89434, February 25, 2014. This study is the first to demonstrate the active presence of the Ergothioneine Transporter in nerve cells in the brain and the ability of Ergothioneine to promote nerve cell production and differentiation. The significance to healthcare is the potential use of Ergothioneine in the repair of injured areas of the brain in stroke and neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, MS, etc.

– L-Ergothioneine Protects Skin Cells against UV-Induced Damage – A Preliminary study. Karolina Bazela, Aleksandra Solyga-Zurek, Renata Debowska, Katarzyna Rogiewicz, Ewa Bartnik and Irena Eris. Cosmetics, March 2014, 1, 51-60. The scientists in this study demonstrated that Ergothioneine enhanced the level of reduced glutathione and protected cells against photoaging and DNA damage. The importance to our Company is that this paper validates the ingredients in Entia’s Groh® medical luxury cosmetic line as effective skin care and anti-photoaging products.

These independent studies underscore the potential commercial value of the products under development by your company as cosmeceuticals and medical foods.

Your company hasn’t been standing still while all this great medical/scientific effort progresses around the world outside Entia. In 2014, we experienced several Company advances that should reward us with substantial benefits as we roll-out the GROH® medical luxury line of cosmetic products and continue our work towards marketing a medical food.

– Most important, Entia initiated in 3rd-4th quarter 2014 a GROH® ‘skin’ benefits research study. We tested and studied 27 subjects, who used our GROH® Skin Treatment program on a daily basis for 3 months. Subjects were reevaluated biweekly with examination, photo confirmation, and a blinded questionnaire. Study findings are now being collated and analyzed and, of course, subjects have voiced their personal opinions regarding their responses to the products used. Management was pleased and excited to hear these very premature (anecdotal) findings. Now this may seem like a little “bait and switch” tactic, but I’m not going to relay either the findings or results at this point. Please understand that my purpose is solely supported by greed. We all want the results of this study to end-up in some prestigious journal so that it will be read by ‘thought leaders’, included in class work and lectures, and certainly shared by the Company to support our GROH revenue sales. It so happens that sharing of this kind of work may preclude a formal publication of the findings and research results in a journal if it is released in any form prior to publication consideration. Expect an announcement on this research effort before the end of June 2015.

– Another effort that is underway and was announced is the grant received from Michael J Fox Foundation (MJFF) to conduct a preclinical study of our ErgoD2® medical food formulation as a potential therapy for Parkinson’s disease (PD). This study is a follow-up study to the initial study successfully conducted in collaboration with Dr. Jack Rogers, Ph.D., at the Massachusetts General Hospital Neurochemistry Laboratory, in which ErgoD2® was shown to increase muscle strength and reduce the toxic buildup of midbrain alpha-synuclein levels. This exciting research effort toward helping those stricken by PD and financed by the MJFF heightens the value of our scientific research work with our foundational platform technology products Ergothioneine and vitamin D2. With the successful conclusion of the second study, performed by independent clinical research organizations (CRO’s) we hope to receive more support from the MJFF regarding follow-on scientific studies to advance PD treatments.

– Lastly, I was asked to speak at the 17th International Functional Food Conference (November 18-19, 2014), San Diego, CA, and also Chair a session, entitled “Legislation on Health Claims: Healthy, Functional and Medical Foods.” The title of my talk at this conference, which was also co-sponsored by the USDA, was “Treatment of Anemia with a Natural Mushroom-Based Medical Food ErgoD2.”

To round out this discussion of 2014, we do need to relay what is happening to our Company from a commercial standpoint. Let’s start at the beginning.

The big news for last year concerns Entia’s beauty line of products, GROH®. GROH®, a boutique medical luxury line represents an evolution in natural and organic products that target the health conscious consumer through high end salons and day spas. This new category of beauty products has been coined ‘The Beauty of Wellness’. As you may recall, our Company began selectively positioning Groh® within the industry’s premier organizations, thought leaders, and trend setters in February of 2014. They include Mario Tricoci (Chicago), Gadabout Salon (Arizona), Visible Changes (Houston), Gene Juarez (Seattle), Anastasia (Portland), and many others. Furthermore, on March 16th, 2015, we will be launching nationally with Elizabeth Arden’s Red Door Spa at their annual symposium in Atlantic City. All in all, there were roughly 100 plus high end salons around the country that tried, bought, liked and continued to purchase with follow-on orders of our GROH® Ergo Boost line of products.

The success of managements positioning campaign made it possible for Entia to execute an agreement with Star Companies (Star), one of the largest independent cosmetic distributors in the US, servicing more than 24,000 salons nation-wide. The Star’s family of companies are known to the industry for their ability to successfully enter new products into the market, currently distributing many professional brands for companies like L’Oreal including Redken and Pureology.

Over the last two months—December 2014 and January 2015, we have prepared and shipped a major “stocking” order for Star, launched the necessary support advertising campaigns, provided operator informational and ‘certification’ presentations and shipped what was the largest single order in our Company’s history.

I’m so excited to convey to shareholders that our 2014 year-end quarter…we not only had the ‘fill-in’ order for the Star distribution organization, but we continued to have strong sales for our mushroom food supplements in the European Veterinary space as well as continuing orders from a long-standing, off-shore beverage client.

Going forward, expect a number of activities that should magnify our operating successes as well as prompt new strength in our share price. They include:

– Progress on the Parkinson’s disease and Groh® skincare studies as well as other research opportunities that we believe should surface in the new year.

– Continued orders for our cosmeceutical products, manifested primarily via added ‘sell-through’ sales by our distribution partner; New Groh® sales regions that our partner may open; as well as corporate distribution opportunities in regions not covered by the Star agreement.

– A concerted effort to enter the major drug/grocery retail chain arena with off-brand supplement products.

As a scientist and long-term medical professional, I am very hopeful that the scientific effort by Entia and other research institutes and programs will continue to provide further evidence that ErgoD2® provides life enhancing attributes to human biology and well-being. And by doing so, there is a chance that medical research will conclude, like it did in the late-1960’s and 1970s with Vitamin C, that Entia and its platform ErgoD2® breakthrough technology is exactly situated at the right place, right time and with the right products to help improve beauty, enhance health and treat many human and animal maladies.

We, at Entia, thank you for your support, and look forward to continued corporate progress in 2015 as we take advantage of both scientific and commercial opportunities.

Marvin S. Hausman MD

CEO and Chairman

About Entia Biosciences, Inc.:

Entia is an authority on the clinical effects of oxidative stress and free radical reactions and is bringing this expertise to the fields of food science biotechnology and Nutrigenomics. The Company identifies, scientifically validates, patents, and commercializes solutions that address multi-billion dollar markets for health, beauty and agriculture. www.entiabio.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Entia Biosciences with the Securities and Exchange Commission. Further information on risks faced by the Company and its shareholders are detailed in the Form 10-K for the year ended December 31, 2013 and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Entia does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

CONTACT:

Devin Andres

Chief Operating Officer

Entia Biosciences, Inc.

13565 SW Tualatin-Sherwood Rd.

Sherwood, OR 97140 | (503) 334-3575; (503) 334-3575 | info

SOURCE: Entia Biosciences, Inc.

Seven Arts Entertainment Provides Shareholder Update

LOS ANGELES, CA, United States, via ETELIGIS INC., 02/24/2015 – – Seven Arts Entertainment, Inc. (now known as WirelessConnect, Inc.) (OTC Pink: SAPX) (PINKSHEETS: SAPX) (“Seven Arts” or the “Company”), a diversified company with motion picture production assets and wireless communications, is pleased to provide a shareholder update.

Recently Seven Arts became aware that its current auditing firm is going thru an audit review by the Public Company Oversight Board (“PCAOB” www.pcaob.org) which has prevented the auditing firm from issuing opinion letters to its clients including Seven Arts. This action has delayed the completion of Seven Arts audited financial statements and the filing of its 10-K for the fiscal year ended 6/30/2014, and the two quarterly 10-Qs for the periods ending on 9/30/2014 and 12/31/2014. Seven Arts is in the process of selecting another auditing firm to complete its 2014 fiscal year end and quarterly reviews.

As an interim course of action, Seven Arts has determined it’s best to file Form 15 with the SEC and become a non-reporting issuer until the 10-K and 10-Qs are completed and filed. The Company will also apply to the OTC Markets Disclosure Services where it will file its 10-Ks and 10-Qs until it becomes a reporting issuer. The Company will continue to trade on the OTC Markets under symbol SAPX.

About Seven Arts Entertainment, Inc.:

Seven Arts Entertainment, Inc. is a global diversified company with wireless communications and motion picture production assets. Seven Arts vertically integrated portfolio of solutions target a diverse array of enterprises and multiple disciplines. Seven Arts owns 60% of Seven Arts Filmed Louisiana which holds all rights to Seven Arts movie assets; 100% of iPTerra Technologies, Inc., a designer, developer, manufacturer and marketer of a real-time 2-way wireless and/or wireline communications, and mine-safety solution for the global mining industry (www.ipterra.net); and 100% of Aeronetworks, a provider of advanced telecommunications and broadband services to niche markets including entertainment venues, rural communities and Native American tribes (www.aeronetworks.net).

Cautionary Information Regarding Forward-Looking Statements:

Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated. The information contained in this release is as of February 24, 2015. Seven Arts assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

CONTACT:

Seven Arts Entertainment, Inc.

Rick Bjorklund, Chairman and CEO

rick

SOURCE: Seven Arts Entertainment, Inc.

eDoorways Taking Steps to Reduce AS and OS

HOUSTON, TX, United States, via ETELIGIS INC., 02/24/2015 – – eDoorways International Corporation (OTC Pink: EDWY) (PINKSHEETS: EDWY), today announced that it is taking immediate steps to reduce the number of authorized common shares (AS) as well as the number of outstanding shares (OS).

An EDWY affiliate shareholder has indicated its interest in relinquishing 1 billion common shares for immediate return to the company’s treasury. Steps are now being taken to effectuate the decision. Upon completion of this action EDWY’s Board of Directors will provide its consent to reduce the company’s authorized shares from 2,500,370,900 shares to 1,500,370,900 shares.

EDWY anticipates that the steps to reduce its AS and OS will be completed within thirty business days or less. Arne M Ray, Director Tempore explains, “We are taking positive steps to increase EDWY’s value in the marketplace. It should be noted that the reduction in our OS is being made at the recommendation of our majority shareholder. The shareholder has already relinquished its voting control. Now our majority holder is taking the unprecedented step of surrendering a large portion of its common holdings to move EDWY in a positive direction. We appreciate this action and anticipate significant progress in other areas as we move forward.”

Please visit EDWY’s website at info.

Safe Harbor for Forward-Looking Statements:

Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company’s actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the company’s domestic and international operations, imprecision in estimating product reserves and the company’s ability to replace and expand its holdings.

CONTACT:

Arne M Ray, Director Tempore

Houston, Texas

(713) 627-7111

SOURCE: eDoorways International Corporation